Von Knebel, K., Staab, J., Gregus, A., Remling, L., Wirths, O., Spizer, C., Herrmann-Lingen, C., Reichardt H.M., and Meyer, T. (2025). Social inhibition in depressed patients is associated with an altered activation profile of the interleukin-6-inducible transcription factor STAT3. Brain Behav Immun Health 44, 199968.

Klaus, L., Reichardt, S.D., Neif, M., Walter, L., Gayer, F.A., and Reichardt H.M. (2024). Teratoma development in 129.MOLF-Chr19 mice elicits two waves of imune cell infiltration. Int J Mol Sci 25, 12750.

Gayer, F.A., Klaus, L., Reichardt, S.D., Fichtner, A., and Reichardt H.M. (2024). Phenotype and gene signature of testicular tumors in 129.MOLF-Chr19 mice resemble human teratomas. Andrology, doi: 10.1111/andr.13717.

Albers, G.J., Amouret, A., Ciupka, K., Montes-Cobos, E., Feldman, C., and Reichardt H.M. (2023). Glucocorticoid nanoparticles show full therapeutic efficacy in a mouse model of acute lung injury and concomitantly reduce adverse effects. Int J Mol Sci 24, 16843.

Gayer, F.A., Henkel, M., Luft, J., Reichardt, S.D., Fichtner, A., Legler, T.J., and Reichardt H.M. (2023). The Subtype Identity of Testicular Cancer Cells Determines their Immunostimulatory Activity in a Coculture Model. Cancers 15, 2619.

Meyer-Heemsoth, L., Mitschke, K., Bier, J., Schütz, K., Villunger, A., Legler, T.J., Weber, M.S., Lühder, F., and Reichardt, H.M. (2023). T Cell Energy Metabolism is a Target of Glucocorticoids in Mice, Healthy Humans, and MS patients. Cells 12, 450.

Gayer, F.A., Fichtner, A., Legler, T.J., and Reichardt H.M. (2022). A coculture model mimicking the tumor microenvironment unveils mutual interactions between immune cell subtypes and the human seminoma cell line TCam-2. Cells 11, 885.

Gayer, F.A., Reichardt, S.D., Bohnenberger, H., Engelke, M., and Reichardt H.M. (2022). Characterization of testicular macrophage subpopulations in mice. Immunol Lett 243, 44.

Reichardt, S.D., Amouret, A., Muzzi, C., Vettorazzi, S., Tuckermann, J.P., Lühder, F., and Reichardt H.M. (2021). The role of glucocorticoids in inflammatory diseases. Cells 10, 2921.

Bier, J., Steiger, S.M., Reichardt, H.M.*, and Lühder, F.* (2021). Protection of antigen-primed effector T cells from glucocorticoid-induced apoptosis in cell culture and in a mouse model of multiple sclerosis. Front Immunol 12, 671258. *shared senior authorship

Reichardt, S.D., Lühder, F., Wiegers, G.J., and Reichardt, H.M. (2021). A flow cytometric approach to study glucocorticoid receptor expression in immune cell subpopulations of genetically engineered mice. Immunol Lett 233, 68.

Muzzi, C., Watanabe, N., Twomey, N., Meers, G.K., Reichardt, H.M., Bohnenberger, H., and Reichardt, S.D. (2021). The glucocorticoid receptor in intestinal epithelial cells alleviates colitis and associated colorectal cancer in mice. Cell Mol Gastroenterol Hepatol 11, 1505.

Kaiser, T.K., Li, H., Roßmann, L., Bohnenberger, H., Reichardt, S.D., Feldmann, C., and Reichardt, H.M. (2020). Glucocorticoids delivered by inorganic-organic hybrid nanoparticles mitigate acute graft-versus-host disease and sustain graft-versus-leukemia activity. Eur J Immunol 50, 1220.

Kaiser, T.K., Khorenko, M., Moussavi, A., Engelke, M., Boretius, S., Feldmann, C., and Reichardt, H.M. (2020). Highly selective organ distribution and cellular uptake of inorganic-organic hybrid nanoparticles customized for the targeted delivery of glucocorticoids. J Contr Release 319, 360-370.

N’diaye, M., Brauner, S., Flytzani, S., Kular, L., Warnecke, A., Adzemovic, M.Z., Piket, E., Min, J.H., Edwards, W., Mela, F., Choi, H.Y., Magg, V., James, T., Linden, M., Reichardt, H.M., Daws, M.R., van Horssen, J., Kockum, I., Harris, R.A., Olsson, T., Guerreiro-Cacais, A.O., Jagodic, M. (2020). C-type lectin receptors Mcl and Mincle control development of multiple sclerosis-like neuroinflammation. J Clin Invest 130(2), 838.

Li, H., Kaiser, T.K., Borschiwer, M., Bohnenberger, H., Reichardt, S.D., Lühder, F., Walter, L., Dressel, R., Meijsing, S.H., and Reichardt, H.M. (2019). Glucocorticoid resistance in T cells alters the gene expression profile in the inflamed small intestine of mice suffering from acute graft-versus-host disease. J Steroid Biochem Mol Biol 195, 105485.

Fischer, H.J., Finck, T.L.K., Pellkofer, H.L., Reichardt, H.M.*, and Lühder, F.* (2019). Glucocorticoid therapy of multiple sclerosis patients induces anti-inflammatory polarization and increased chemotaxis of monocytes. Front Immunol 10, 1200. *shared senior authorship

Hoepner, R., Bagnoud, M., Pistor, M., Salmen, A., Briner, M., Synn, H., Schrewe, L., Guse, K., Ahmadi, F., Demir, S., Laverick, L., Gresle, M., Worley, P., Reichardt, H.M., Butzkueven, H., Gold, R., Metz, I., Lühder, F., and Chan, A. (2019). Vitamin D increases glucocorticoid efficacy via inhibition of mTORC1 in experimental models of multiple sclerosis. Acta Neuropathol 138, 443.

Lodygin, D., Hermann, M., Schweingruber, N., Flügel-Koch, C., Watanabe, T., Schlosser, C., Merlini, A., Körner, H., Chang, H.F., Fischer, H.J., Reichardt, H.M., Zagrebelsky, M., Mollenhauer, B., Kügler, S., Fitzner, D., Frahm, J., Stadelmann, C., Haberl, M., Odoardi, F., and Flügel, A. (2019). b-Synuclein-reactive T cells induce autoimmune CNS grey matter degeneration. Nature 566, 503.